Methods of international health technology assessment agencies for economic evaluations- a comparative analysis

被引:54
|
作者
Mathes, Tim [1 ]
Jacobs, Esther [1 ]
Morfeld, Jana-Carina [1 ]
Pieper, Dawid [1 ]
机构
[1] Univ Witten Herdecke, Fac Hlth, Sch Med, Inst Res Operat Med, D-51109 Cologne, Germany
来源
关键词
COST-EFFECTIVENESS; DECISION-MAKING; ASSESSMENT ORGANIZATIONS; KEY PRINCIPLES; GUIDELINES; CARE; GENERALIZABILITY; UNCERTAINTY;
D O I
10.1186/1472-6963-13-371
中图分类号
R19 [保健组织与事业(卫生事业管理)];
学科分类号
摘要
Background: The number of Health Technology Assessment (HTA) agencies increases. One component of HTAs are economic aspects. To incorporate economic aspects commonly economic evaluations are performed. A convergence of recommendations for methods of health economic evaluations between international HTA agencies would facilitate the adaption of results to different settings and avoid unnecessary expense. A first step in this direction is a detailed analysis of existing similarities and differences in recommendations to identify potential for harmonization. The objective is to provide an overview and comparison of the methodological recommendations of international HTA agencies for economic evaluations. Methods: The webpages of 127 international HTA agencies were searched for guidelines containing recommendations on methods for the preparation of economic evaluations. Additionally, the HTA agencies were requested information on methods for economic evaluations. Recommendations of the included guidelines were extracted in standardized tables according to 13 methodological aspects. All process steps were performed independently by two reviewers. Results: Finally 25 publications of 14 HTA agencies were included in the analysis. Methods for economic evaluations vary widely. The greatest accordance could be found for the type of analysis and comparator. Cost-utility-analyses or cost-effectiveness-analyses are recommended. The comparator should continuously be usual care. Again the greatest differences were shown in the recommendations on the measurement/sources of effects, discounting and in the analysis of sensitivity. The main difference regarding effects is the focus either on efficacy or effectiveness. Recommended discounting rates range from 1.5% - 5% for effects and 3% - 5% for costs whereby it is mostly recommended to use the same rate for costs and effects. With respect to the analysis of sensitivity the main difference is that oftentimes the probabilistic or deterministic approach is recommended exclusively. Methods for modeling are only described vaguely and mainly with the rational that the "appropriate model" depends on the decision problem. Considering all other aspects a comparison is challenging as recommendations vary regarding detailedness and addressed issues. Conclusion: There is a considerable unexplainable variance in recommendations. Further effort is needed to harmonize methods for preparing economic evaluations.
引用
收藏
页数:10
相关论文
共 50 条
  • [41] The UKNHS Economic Evaluation Database - Economic issues in evaluations of health technology
    Stoykova, B
    Glanville, J
    Christie, J
    Drummond, M
    Kleijnen, J
    INTERNATIONAL JOURNAL OF TECHNOLOGY ASSESSMENT IN HEALTH CARE, 2000, 16 (03) : 731 - 742
  • [42] What influences the choice of assessment methods in health technology assessments? Statistical analysis of international health technology assessments from 1989 to 2002
    Draborg, E
    Andersen, CK
    INTERNATIONAL JOURNAL OF TECHNOLOGY ASSESSMENT IN HEALTH CARE, 2006, 22 (01) : 19 - 25
  • [43] Strategic objectives of Health Regulatory Agencies: an international comparative study
    de Brito, Rodrigo Lino
    Coimbra Flexa, Raquel Goncalves
    VIGILANCIA SANITARIA EM DEBATE-SOCIEDADE CIENCIA & TECNOLOGIA, 2019, 7 (03): : 3 - 13
  • [44] TRANSFERABILITY INDICES FOR HEALTH ECONOMIC EVALUATIONS: METHODS AND APPLICATIONS
    Antonanzas, Fernando
    Rodriguez-Ibeas, Roberto
    Juarez, Carmelo
    Hutter, Florencia
    Lorente, Reyes
    Pinillos, Mariola
    HEALTH ECONOMICS, 2009, 18 (06) : 629 - 643
  • [45] ECONOMIC EVALUATIONS OF SUBCUTANEOUSLY ADMINISTERED ONCOLOGY THERAPIES: A HEALTH TECHNOLOGY ASSESSMENT (HTA) LANDSCAPE REVIEW
    Wu, E.
    Schenkel, B.
    Povsic, M.
    Wyn, R.
    Hernani, M.
    Kornalska, K.
    VALUE IN HEALTH, 2019, 22 : S77 - S77
  • [46] Methods, procedures, and contextual characteristics of health technology assessment and health policy decision making: Comparison of health technology assessment agencies in Germany, United Kingdom, France, and Sweden
    Schwarzer, Ruth
    Siebert, Uwe
    INTERNATIONAL JOURNAL OF TECHNOLOGY ASSESSMENT IN HEALTH CARE, 2009, 25 (03) : 305 - 314
  • [47] ANALYSIS OF FACTORS ASSOCIATED WITH REIMBURSEMENT DECISION MAKING IN HEALTH TECHNOLOGY ASSESSMENT AGENCIES (HTA)
    Bending, M. W.
    Kruger, J.
    Hutton, J.
    McGrath, C.
    VALUE IN HEALTH, 2008, 11 (06) : A377 - A377
  • [48] DEVELOPMENT OF A TOOL FOR QUALITY ASSESSMENT OF HEALTH ECONOMIC EVALUATIONS
    Migliavaca, Borges C.
    Escher, G. N.
    Schneider, N. B.
    Graf, Dalmas D.
    Stein, C.
    Decker, S. R. D. R.
    Falavigna, M.
    Polanczyk, C. A.
    VALUE IN HEALTH, 2024, 27 (06) : S98 - S98
  • [49] ANALYSIS OF TRANSPARENCY AMONGST INTERNATIONAL HEALTH TECHNOLOGY ASSESSMENT ORGANIZATIONS
    Jebrail, F.
    Duong, M.
    Shum, D.
    VALUE IN HEALTH, 2013, 16 (07) : A481 - A482
  • [50] EVALUATING CHATGPT'S EFFICACY AND EFFICIENCY IN THE RISK OF BIAS ASSESSMENT IN HEALTH ECONOMIC EVALUATIONS: A COMPARATIVE ANALYSIS USING THE DRUMMOND CHECKLIST
    Ohra, S.
    C, R. R.
    Siddiqui, M. T.
    Gupta, J.
    Siddiqui, M. K.
    VALUE IN HEALTH, 2024, 27 (06) : S13 - S13